Conducting Clinical Trials Part 4: Financial Conflicts of Interest

Clinical trials have found their way into the spotlight of the coronavirus pandemic as multiple pharmaceutical and biotechnology companies race to develop and market vaccines and therapies. As breakthrough technologies are on the rise, so are the risks associated with vaccine and drug development. “Conducting Clinical Trials” is a podcast miniseries featuring Choate attorneys covering a number of topics related to clinical trials, including common mistakes companies make along the way and various strategic choices they face.

Financial conflicts of interest are quite common in research and clinical trials. They occur when an investigator’s significant financial interest directly and significantly affects the design, conduct, or reporting of research. In this episode of Choate’s Conducting Clinical Trials series, Mark McPherson and Greta Fails cover what financial conflicts of interest are in a clinical trials context, how federal funding agencies regulate them, and enforcement trends.

 Listen to additional episodes →